Cancer Flashcards
Antifolates drugs
Methotrexate
Raltitrexed
Pemetrexed
Pyrimidine analogs
5-fluorouracil Tegafur Capecitabine Trifluridine Tipiracil
Purine analogs
6-mercaptopurine
6-thioguanine
Fludarabine
Nelarabine
Deoxycytidine analogues
Gemcitidine
Cytarabine
Inhibition of RNA reductase
Hydroxycarbamide
Hydroxyurea
Alkylating agents nitrogen mustard derivatives
Cyclophosphamide
Ifosfamide
Melphalon
Thiotepa
Alkylating agents Nitrosurea
Carmustine
Lomustine
Alkylting drugs platinium analogs
Cisplatin
Carboplastin
Oxaliplatin
Other dna alkylating for glioma
Busulfan
Temozolomide
Dacarbazine
Procarbazine
Antibiotics
Bleomycin (in G2 phase)
Actinomycin D
Topoisomerase I inhibitors
Irinotecan
Topotecan
Topoisomerase II Anthracyclines
Doxorubicin
Daunorubicin
Epirubicin
Idarubicin
Topoisomerase II inhibitors Antracenediones
Mitoxantrone
Topoisomerase II inhibitors Epidophyllotoxins
Etoposide
Teniposide
Taxanes
Paclitaxel
Docetaxel
They inhibit the depolymerization
Vinca alkaloids !!! Pediatrics
Vincristine
Vinblastine
Others
Estramustine phosphate
Mitotane
Bexarotene
Glucocorticoids for cancer
Prednisolone
Methylprednisolone
Dexamethasone
Progestins
Medroxyprogesterone
Megestrol
Anti estrogen
Tamoxifen
Toremifene
Fulvestrant
Aromatase inhibitors
Anastrozole
Exemestane
Antiandrogen
Flutamide
Bicalutamide
LH-RH analogs
Buserelin
Goserelin
Leuprolide
Gn-RH inhibitors
Degarelix
Carcinoid tumor drug
Octreotide
MTOR inhibitors
Everolimus
Temsirolimus
Receptor tyrosine kinase inhibit ABL/Ckit/PDGFR
Imatinib
Receptor tyrosine kinase HER2 + EGFR antagonist
Lapatinib
Receptor tyrosine kinase EGFR selective antagonist
Afatinib
Gefitinib
Erlotinib
Receptor tyrosine kinase Bruton tyrosine kinase inhibitor
Ibrutinib
Receptor tyrosine kinase multiple GFR antagonist
Sorafenib
Sunitinib
Receptor tyrosine kinase selective VEGFR 1,2,3 antagonist
Axitinib
Multiple tyrosine kinase inhibitors
Regorafenib
Receptor tyrosine kinase anaplastic lymphoma kinase inhibitor
Crizotinib
Certinib
Receptor tyrosine kinase BRAF kinase inhibitors
Vemurafenib
Dabrafenib
Receptor tyrosine kinase MAP kinase inhibitor
Trametinib
Proteasome inhibitor
Bortezomib
BCL-2 protein inhibitor
Venetoclax
Retinoids
Tretinoin
Alitretinoin
Bexaroten
Monoclonal antibody against CD20
Rituximab
Anti -EGFR mab
Cetuximab
Panitumumab
Anti HER-2
Trastuzumab + emtansin (MT inhibitor)
Anti-IL-2
Aldesleukin
2 binding sites: CD3 and CD19
Blinatumomab
3 binding sites: CD3, macrophages and EpCAM
Catamaxomab
Binds CTLA-4
Ipilimumab
Binds PD-1
Pembrolizumab
Human IgG4 mab which binds PD-1
Nivolumab
Anti VEGF-A antibody
Bevacizumab